BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan D, Vasu S, Moffett RC, Gault VA, Flatt PR, Irwin N. Locally produced xenin and the neurotensinergic system in pancreatic islet function and β-cell survival. Biological Chemistry 2017;399:79-92. [DOI: 10.1515/hsz-2017-0136] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lafferty RA, O’harte FP, Irwin N, Flatt PR, Gault VA. Pharmacology of Gut Hormone Mimetics for Obesity and Diabetes. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00035-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Atanes P, Ruz-maldonado I, Persaud SJ. Targeting Islet GPCRs to Improve Insulin Secretion. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00050-5] [Reference Citation Analysis]
3 Khan D, Moffett RC, Flatt PR, Tarasov AI. Classical and non-classical islet peptides in the control of β-cell function. Peptides 2021;:170715. [PMID: 34958851 DOI: 10.1016/j.peptides.2021.170715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Craig SL, Irwin N, Gault VA. Xenin and Related Peptides: Potential Therapeutic Role in Diabetes and Related Metabolic Disorders. Clin Med Insights Endocrinol Diabetes 2021;14:11795514211043868. [PMID: 34588834 DOI: 10.1177/11795514211043868] [Reference Citation Analysis]
5 Mohan S, Flatt PR, Irwin N, Moffett RC. Weight-reducing, lipid-lowering and antidiabetic activities of a novel arginine vasopressin analogue acting at the V1a and V1b receptors in high-fat-fed mice. Diabetes Obes Metab 2021. [PMID: 34105240 DOI: 10.1111/dom.14462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Onaga T, Hayashi H, Yasui Y. Effects of xenin-25 on insulin and glucagon secretions in healthy conscious sheep. Domest Anim Endocrinol 2021;77:106635. [PMID: 34111624 DOI: 10.1016/j.domaniend.2021.106635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Craig SL, Gault VA, Shiels CE, Hamscher G, Irwin N. Comparison of independent and combined effects of the neurotensin receptor agonist, JMV-449, and incretin mimetics on pancreatic islet function, glucose homeostasis and appetite control. Biochim Biophys Acta Gen Subj 2021;1865:129917. [PMID: 33964357 DOI: 10.1016/j.bbagen.2021.129917] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mohan S, McCloskey AG, McKillop AM, Flatt PR, Irwin N, Moffett RC. Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice. Biochim Biophys Acta Gen Subj 2021;1865:129811. [PMID: 33309687 DOI: 10.1016/j.bbagen.2020.129811] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
9 Craig SL, Gault VA, Flatt PR, Irwin N. The methionine aminopeptidase 2 inhibitor, TNP-470, enhances the antidiabetic properties of sitagliptin in mice by upregulating xenin. Biochem Pharmacol 2021;183:114355. [PMID: 33279496 DOI: 10.1016/j.bcp.2020.114355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lafferty RA, Tanday N, Flatt PR, Irwin N. Generation and characterisation of C-terminally stabilised PYY molecules with potential in vivo NPYR2 activity. Metabolism 2020;111:154339. [PMID: 32777442 DOI: 10.1016/j.metabol.2020.154339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Tanday N, Moffett RC, Gault VA, Flatt PR, Irwin N. Enzymatically stable analogue of the gut-derived peptide xenin on beta-cell transdifferentiation in high fat fed and insulin-deficient Ins1Cre/+ ;Rosa26-eYFP mice. Diabetes Metab Res Rev 2021;37:e3384. [PMID: 32662136 DOI: 10.1002/dmrr.3384] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hasib A, Khan D, Craig SL, Gault VA, Flatt PR, Irwin N. Antidiabetic effects and sustained metabolic benefits of sub-chronic co-administration of exendin-4/gastrin and xenin-8-Gln in high fat fed mice. Eur J Pharmacol 2019;865:172733. [PMID: 31614140 DOI: 10.1016/j.ejphar.2019.172733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 English A, Irwin N. Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions. Clin Med Insights Endocrinol Diabetes 2019;12:1179551419888871. [PMID: 32425629 DOI: 10.1177/1179551419888871] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Sarnobat D, Moffett RC, Gault VA, Tanday N, Reimann F, Gribble FM, Flatt PR, Irwin N. Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic GluCreERT2;ROSA26-eYFP mice. Peptides 2020;125:170205. [PMID: 31738969 DOI: 10.1016/j.peptides.2019.170205] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
15 Craig SL, Gault VA, McClean S, Hamscher G, Irwin N. Effects of an enzymatically stable C-terminal hexapseudopeptide fragment peptide of xenin-25, ψ-xenin-6, on pancreatic islet function and metabolism. Mol Cell Endocrinol 2019;496:110523. [PMID: 31352038 DOI: 10.1016/j.mce.2019.110523] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
16 Mohan S, Moffett RC, Thomas KG, Irwin N, Flatt PR. Vasopressin receptors in islets enhance glucose tolerance, pancreatic beta-cell secretory function, proliferation and survival. Biochimie 2019;158:191-8. [DOI: 10.1016/j.biochi.2019.01.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
17 Blondeau N, Béraud-Dufour S, Lebrun P, Hivelin C, Coppola T. Sortilin in Glucose Homeostasis: From Accessory Protein to Key Player? Front Pharmacol 2018;9:1561. [PMID: 30697159 DOI: 10.3389/fphar.2018.01561] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
18 Hasib A, Ng MT, Tanday N, Craig SL, Gault VA, Flatt PR, Irwin N. Exendin-4(Lys 27 PAL)/gastrin/xenin-8-Gln: A novel acylated GLP-1/gastrin/xenin hybrid peptide that improves metabolic status in obese-diabetic ( ob/ob ) mice. Diabetes Metab Res Rev 2019;35:e3106. [DOI: 10.1002/dmrr.3106] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
19 Paternoster S, Falasca M. Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1. Front Endocrinol (Lausanne) 2018;9:584. [PMID: 30364192 DOI: 10.3389/fendo.2018.00584] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
20 Hasib A, Ng MT, Khan D, Gault VA, Flatt PR, Irwin N. Characterisation and antidiabetic utility of a novel hybrid peptide, exendin-4/gastrin/xenin-8-Gln. European Journal of Pharmacology 2018;834:126-35. [DOI: 10.1016/j.ejphar.2018.07.027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
21 Craig SL, Gault VA, Irwin N. Emerging therapeutic potential for xenin and related peptides in obesity and diabetes. Diabetes Metab Res Rev 2018;34:e3006. [PMID: 29633491 DOI: 10.1002/dmrr.3006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
22 Khan D, Moffet CR, Flatt PR, Kelly C. Role of islet peptides in beta cell regulation and type 2 diabetes therapy. Peptides 2018;100:212-8. [DOI: 10.1016/j.peptides.2017.11.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
23 Mohan S, Khan D, Moffett RC, Irwin N, Flatt PR. Oxytocin is present in islets and plays a role in beta-cell function and survival. Peptides 2018;100:260-8. [PMID: 29274352 DOI: 10.1016/j.peptides.2017.12.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]